Rheumatology Therapeutics Market
A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market.
A report by Transparency Market Research uncovers after in-depth study that the global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025 to become worth US$ 52.96 bn by 2025 from US$41.88 bn in 2016.
Read Report Overview:https://www.transparencymarketresearch.com/rheumatology-therapeutics-market.html
Depending upon the drug class, the key segments of the global rheumatology disorder market are disease modifying anti-rheumatic drugs (DMARDs), non-steroidal anti-inflammatory drugs (NSAID’s), corticosteroids, uric acid drugs, etc. The DMARDs, which is a group of medicines or combination of medicines used to treat rheumatic diseases by blocking the inflammation, accounts for maximum shaee in the market at present. They are categorized into two major types - biologic DMARDs and synthetic DMARDs.
The biologic DMARDs are mostly used for the treatment of various rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The patent expiry of top brands such as Humira, however, is expected to deal a blow to the growth in the segment. Market pundits predict the challenge will eventually be overcome by the wide pipeline of other biologics such as interleukin-6. By rising at a 2.6% CAGR from 2017 to 2025, the segment is projected to pull in a revenue of US$45.06 bn by 2025 from US$35.83 bn in 2016. Azathioprine, cyclophosphamide, cyclosporine, and methotrexate are highly used synthetic DMARDs for the treatment of rheumatic diseases.
Obtain the Brochure of the Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1494
In terms of growth rate, corticosteroids are anticipated to surpass all other segments by clocking a CAGR of 4.4% from 2017 to 2025. Rising at this rate, the segment is projected to pull in a revenue of US$1.22 bn by 2025. Their increasing use in developing countries will likely boost their demand.
Substantial Elderly Population Drives North America Market
From a geographical standpoint, North America accounts for a leading share in the global rheumatology therapeutics market because of a rapid rise in the elderly population, who are afflicted with different types of rheumatology disorders. In addition to that, adoption of biologics and biosimilars products for the treatment of moderate to severe rheumatoid arthritis and well-established healthcare facilities has also provided a major boost to the market in the region. Europe trails North America vis-à-vis market size. In terms of growth rate, however, Asia Pacific is predicted to lead. This is because of the significant proportion of population suffering from rheumatoid arthritis and osteoarthritis, increasing per capita healthcare expenditure and approvals of biosimilars for the treatment of several types of rheumatology disorders.
Perceive the Sample of the Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1494
Prominent companies operating in the global rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc. etc. accounted for the major share in global rheumatology therapeutics market in 2016. The other global players operating in the market include Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Sanofi, and Takeda Pharmaceutical.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rheumatology Therapeutics Market here
News-ID: 1562671 • Views: 735
More Releases from Transparecny Market Research
Petroleum Jelly Market Export Research Report and Forecast to 2031
Negative Influence of COVID-19 Pandemic on Petroleum Jelly Market The COVID-19 pandemic has affected the petroleum jelly market to a considerable extent. The low demand from end-use industries led to a decline in the growth rate of the petroleum jelly market. Frequent lockdowns due to the emerging variants of the novel coronavirus caused disruptions in the production process. It also led to disturbances in the supply chain mechanisms. This aspect has
Lactic Acid & Polylactic Acid Market Historical Analysis and Industry Outlook 20 …
Reaching Sustainable Goals Delayed Due to COVID-19 Pandemic Although the COVID-19 outbreak has had a short-term positive impact on reducing greenhouse gas (GHG) emissions, it has delayed the timeline for reaching sustainable development goals. The adoption of sustainable production processes is linked to high costs. Such findings are anticipated to affect business activities in the lactic acid & polylactic acid market, since stakeholders are bullish on expanding uses of polylactic acid
Dehydrated Vegetables Market to Witness a Pronounce Growth at CAGR during 2018-2 …
Dehydrated Vegetables Market to Witness a Pronounce Growth at CAGR during 2018-2028 Food or vegetables dehydration or drying is a process that is used to eliminate moisture from food products and vegetables as it helps in preservation for long periods of time. Food dehydration is highly adopted as an ideal process to preserve seasonal fruits and vegetables. With easy storage, high nutritional value, and cost effectiveness, dehydrated vegetables have been witnessing
Succinic Acid Market Product Quality, Competitive Analysis and Opportunity Asses …
Succinic Acid Market: Introduction In terms of value, the global succinic acid market is anticipated to expand at a CAGR of ~7% from 2019 to 2027. Succinic acid is widely used in various industries such as pharmaceuticals, chemical, and food. Currently, major proportion of succinic acid is derived from petroleum feedstock Increase in construction and infrastructure development activity is expected to trigger the demand for resin, coating, and polyurethanes, which in
More Releases for DMARDs
Rheumatoid Arthritis (RA) Drugs Market Report 2018: Segmentation by Drug Class ( …
Global Rheumatoid Arthritis (RA) Drugs market research report provides company profile for AbbVie, Biogen, Inc., Bristol-Myers Squibb, Celgene Corporation, Celltrion Inc., Johnson & Johnson, MedImmune, LLC, Merck & Co., Inc., Novartis International AG, Takeda Pharmaceutical Company Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Seropositive Rheumatoid Arthritis Drug Market 2018 to 2023 Industry Overview by …
The Global Seropositive Rheumatoid Arthritis Drug market is expected to register a CAGR of 4.0% during the forecast period of 2018 to 2023. The Seropositive Rheumatoid Arthritis Drug is segmented by Drug Class , product, Treatment , application, end-user, and region. Arthritis means inflammation in a joint. The inflammation is characterized by swelling, pain, and redness within the joint. This type of arthritis is known to cause chronic inflammatory disorder in
Global Rheumatoid Arthritis Drug Market Outlook 2022 Report
“Global Rheumatoid Arthritis Drug Market Outlook 2022” report highlights: * Classification and Molecular Mechanism of Rheumatoid Arthritis Drugs * Synthetic DMARDs as Rheumatoid Arthritis Drug * Biological Agents as Rheumatoid Arthritis Drug * Global Market of Rheumatoid Arthritis Drug * Global Tendencies in Use of Antirheumatics * Global Rheumatoid Arthritis Drug Market Future Prospect Download Report Sample Weblink: https://www.kuickresearch.com/report-global-rheumatoid-arthritis-drug-market-outlook-2022.php For Report Sample Contact: firstname.lastname@example.org Table of Contents Antirheumatoids: Call of Rheumatoid Arthritis 1.1 Prologue towards
Global Rheumatoid Arthritis Drug Market Outlook 2022 Report Download
“Global Rheumatoid Arthritis Drug Market Outlook 2022” report gives comprehensive clinical and non-clinical insight on various trends associated with the rheumatoid arthritis drug market across the developed and developing market. Report helps to identify the basic classification and molecular mechanism of action of rheumatoid arthritis drugs available in the market. The top 5 leading DMARDs (Humira, Enbrel, Remicade, Simponi and Otezla) have dominated the overall anti-rheumatics market with
Download Sample Global Rheumatoid Arthritis Drug Market Outlook 2022
“Global Rheumatoid Arthritis Drug Market Outlook 2022” report highlights: Classification and Molecular Mechanism of Rheumatoid Arthritis Drugs Synthetic DMARDs as Rheumatoid Arthritis Drug Biological Agents as Rheumatoid Arthritis Drug Global Market of Rheumatoid Arthritis Drug Global Tendencies in Use of Antirheumatics Global Rheumatoid Arthritis Drug Market Future Prospect For Report Sample Contact: email@example.com Report Weblink:https://www.kuickresearch.com/report-global-rheumatoid-arthritis-drug-market-outlook-2022.php Table of Contents Antirheumatoids: Call of Rheumatoid Arthritis 1.1 Prologue towards Rheumatoid Arthritis 1.2 Obtainable Treatment for Rheumatoid Arthritis
Rheumatoid Arthritis Drug Market Rheumatoid Arthritis Clinical Pipeline Report 2 …
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Antirheumatoids: Call of Rheumatoid Arthritis 1.1 Prologue towards Rheumatoid Arthritis 1.2 Obtainable Treatment for Rheumatoid Arthritis Molecular Mechanism of Antirheumatoids 2.1 Purpose of DMARDs in Rheumatoid Arthritis 2.2 Role of Biological Agents in Rheumatoid Arthritis 2.2.1 TNF- Inhibitors 2.2.2 Interleukin -1 and IL-6 Blockers Classification of Rheumatoid Arthritis Drugs 3.1